Decision For McNeil In Children's Motrin Suit Notes Limits Of OTC Labeling
This article was originally published in The Tan Sheet
Executive Summary
A federal court ruling cautions that drugs should not be expected to have labels that "guarantee against every conceivable adverse consequence.
You may also be interested in...
Judge Returns Motrin Suit To Trial Court, Reject's J&J's Motion To Dismiss
A California state appeals court rejected Johnson & Johnson's motion to dismiss a claim alleging the firm was negligent for not providing specific warnings about Stevens-Johnson Syndrome on Motrin labels.
High Court’s Wyeth v. Levine Ruling Returns Pre-Emption Status Quo
The Supreme Court's ruling in Wyeth v. Levine dashes pharmaceutical industry hopes for broad protection from state product liability lawsuits, but is not expected to trigger a sea-change in current industry operations
Children’s Motrin Suit Seeks Compensation, New Label For Ibuprofen Product
A lawsuit that alleges Children's Motrin with ibuprofen caused a girl's blindness wants McNeil Consumer & Specialty Pharmaceuticals to clearly list all potential serious adverse reactions on the product's label and compensate the child